On the brink of change: How academic data and machine learning can revolutionize Alzheimer’s drug development
October 4, 2018

In this webinar, hear about current industry challenges in Alzheimer’s drug development and glean insights from key opinion leaders as to why we must explore new clinical approaches. Understand the importance of machine learning and predictive analytics for identifying non-diagnosed prodromal Alzheimer’s disease patients – and why we must tap into this unexplored general population to bring about real advancement.

Learn why innovative approaches to Alzheimer’s drug development are not only necessary, but how they will positively impact the future of Alzheimer’s disease for patients and the medical community alike.

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please note that forms have been updated on SC9 PROD, it may be good to update the SC9 DEV forms with SC9 PROD.